Carbon Ion Therapy vs Proton vs Photon — What Differs, and Where Each Is Available

The difference is the particle in the beam. Photon radiation uses X-rays, which travel right through the body. Protons and carbon ions are charged particles that slow down and stop at a set depth inside you. Carbon ions are the heaviest of the three and damage tumour DNA in a denser, harder-to-repair pattern.

Photon radiation is what most people mean by radiotherapy. X-rays are produced by a linear accelerator, deposit dose on the way in, through the tumour and on the way out, and continue past the target before leaving the body. Modern techniques — IMRT, VMAT and daily image guidance — shape that dose tightly around the tumour, which is why photons remain the standard approach in NCCN and ASTRO guidance for the large majority of cancers that need radiation.

Proton therapy uses hydrogen nuclei. A proton beam releases most of its energy at one chosen depth — the Bragg peak, first described by the physicist William Henry Bragg — and then stops. There is almost no exit dose beyond the tumour. That is a physical advantage: it changes where the dose lands, not what the dose does when it gets there.

Carbon ion therapy uses carbon nuclei, each about twelve times heavier than a proton. Carbon ions also stop at a set depth, so they share the proton's physical advantage. What they add is a biological one: they lay their energy down densely along the track, described as high linear energy transfer, producing clustered DNA breaks that cells find harder to repair. Planners account for this by using a higher relative biological effectiveness than for photons.

Your radiotherapy is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout. CION does not own or operate a linear accelerator or any particle-therapy facility.

Photons treat almost everything. Protons are used where sparing nearby tissue clearly matters, mainly in children and in tumours pressed against critical structures. Carbon ions are used and studied mainly for tumours known to resist conventional radiation. The list narrows sharply as you move from left to right on the table above.

Photon radiation is used across breast, lung, prostate, head and neck, cervix, rectum, brain, lymphoma and many other cancers, and for palliative treatment of painful bone or brain secondaries. If radiation is part of your plan, this is very probably what your team is discussing.

Proton therapy has a recognised role, in ASTRO model policy terms, in situations such as many paediatric tumours — where reducing dose to growing tissue also aims to lower the long-term risk of a second cancer — skull-base tumours such as chordoma and chondrosarcoma, ocular tumours, some brain and spinal tumours, and re-irradiation close to structures already taken to their dose limit.

Carbon ion therapy is reported at the centres that offer it for bone and soft-tissue sarcomas, chordoma and chondrosarcoma, adenoid cystic carcinoma of the salivary glands, mucosal melanoma of the head and neck, selected locally advanced pancreatic cancers, and some recurrences inside a previously irradiated area. A large share of that work sits inside registries and clinical trials rather than routine practice.

Being offered photon radiation is not being offered something lesser. Ask your radiation oncologist to show you the planned dose to each organ at risk — that number, not the name of the particle, is what tells you whether your plan is doing its job.

Carbon ion therapy exists at fewer than twenty centres in the world, as of August 2026, and none of them are in India. The facilities are concentrated in Japan, Germany, Italy, Austria, China and South Korea. Getting carbon ion treatment from Hyderabad means travelling abroad for the entire course.

• Japan — the largest cluster of carbon ion facilities in the world, and where the first hospital-based programme began treating patients in 1994.
• Germany, Italy and Austria — a small number of European centres, several of which treat with both proton and carbon ion beams.
• China and South Korea — a smaller but growing group of centres, with further facilities in planning or construction.
• India — none. There is no carbon ion facility in the country, and any claim otherwise should be verified against the named facility before you pay a deposit.

Proton therapy is a different picture. It is available in India, though only at a small number of specialised centres in a few metro cities, so most patients still relocate for the course. Photon radiation is available widely, at NABH-accredited centres across the country, including the partner centres CION coordinates with in and around Hyderabad.

If you are coordinating for a relative from another city or from overseas, ask about total course length before anything else — it decides how long someone has to stay, and that is usually the hardest part of the plan to arrange late.

Work through it in order, not by enthusiasm. First, is your tumour type one of the defined indications? Second, can a modern photon plan already meet the dose limits for your organs at risk? Third, what do the travel, the time and the cost actually add up to? If the first two answers are no and yes, travelling rarely changes your outcome.

That middle question is the one most families skip. If your radiation oncologist can already keep every organ at risk under its dose limit with a photon plan, then a beam that stops at a set depth has nothing left to improve for your case. The physical advantage of particle therapy only becomes meaningful when a photon plan cannot meet those limits, or when the tissue being spared is growing tissue in a child.

Then there is the part no brochure prints. A course abroad usually means several weeks away, a caregiver alongside you, medical visas, translated reports, referral letters, and accommodation near the centre. Add the weeks it takes to arrange all of that — delay in starting treatment is a real clinical cost, not just an inconvenience.

Cost figures for treatment abroad are indicative only, as of August 2026, and vary widely by country, centre and treatment plan. Ask for a written, itemised estimate that separates treatment, planning, travel and stay before you commit to anything.

• Is my tumour type one of the recognised particle-therapy indications? — this single answer rules the whole question in or out.
• What dose does my photon plan give each organ at risk, and is any of them near its limit? — ask to see the actual numbers.
• Would a proton plan change any of those numbers enough to change my outcome? — a physical difference is not automatically a clinical one.
• Has this area been irradiated before? — prior radiation is one of the strongest reasons a particle beam gets discussed.
• How many weeks would I be away, and who needs to travel with me? — settle this before, not after, you accept a slot.
• Can I have a written, itemised estimate covering treatment, planning, travel and stay? — indicative figures only, as of August 2026, but get them in writing.

• Been told your treatment to the brain and whole spine needs to spare everything in between? That is one of the situations where exit dose matters most — Craniospinal Irradiation: Treating the Brain and Whole Spine explains how it is planned.
• If surgery is part of your plan, a single dose given in theatre is a very different way to use radiation — see Intraoperative Radiotherapy (IORT): One Dose During Surgery.
• There is a fourth particle beam you may hear about, used for shallow targets rather than deep ones: Electron Beam Therapy: Radiation That Stops Just Below the Skin.
• Wondering how “current” the planning itself is, rather than the beam? Artificial Intelligence in Radiation Planning: Auto-Contouring Explained covers what has actually changed in the planning room.
• For the full picture of how radiation is planned, delivered and coordinated with NABH-accredited partner centres, see Radiation Therapy at CION Cancer Clinics.

Still unsure which beam applies to your own tumour? Book a free consultation and a radiation oncologist will go through your scan and your options with you directly.